Roche Withdraws Czech TV Ads
Hoffmann-La Roche's pharmaceutical subsidiary in the Czech Republic has decided to withdraw its successful television advertisements, following the passage of a new law banning the advertising of drugs on television or radio, reports the CTK news agency's Business News. Two Czech television stations, Ceska Televize and Nova, said they wished to broadcast these lucrative ads.
The Ministry of Health is now reported to consider the complete ban on television advertising of medicines to be a mistake, although it will continue to enforce the law and punish offenders, says the Mlada Fronta Daes newspaper. The manager of Roche's Czech subsidiary, Ivo Filipek, reportedly told the newspaper that his company does not want to risk a lawsuit or damage to its reputation by continuing to advertise.
Meantime, Business News notes that the costs of health care in the Czech Republic rose only 2% during December 1993-March 1994. The increase in the first quarter of 1995 was just 0.1%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze